Results 131 to 140 of about 17,718 (201)

Computational Fluid Dynamics Modeling of Intravitreal Ranibizumab Bolus Versus Subretinal ABBV-RGX-314 Transgene Product in Human Eyes. [PDF]

Transl Vis Sci Technol
Park J, Kazemi M, Tamhane M, Shen J.
europepmc   +1 more source

Evaluation of the Duration of Good Visual Acuity During Anti-VEGF Therapy for Age-Related Macular Degeneration in Routine Clinical Practice. [PDF]

Int J Mol Sci
Gyenes A, István L, Papp A, Resch M, Récsán Z, Ecsedy M, Szepessy Z, Szabó A, Lesch B, Barcsay G, Borbándy Á, Sándor GL, Nagy ZZ, Kovács I.   +13 more
europepmc   +1 more source

Aflibercept, ranibizumab, and bevacizumab for macular neovascularization secondary to age-related macular degeneration: a retrospective OCT-angiography study. [PDF]

Int J Retina Vitreous
Lombardo M, Maccauro C, D'Ambrosio M, Grossi M, Missiroli F, Cesareo M, Ricci F.   +6 more
europepmc   +1 more source

Efficacy of dexamethasone intravitreal implant combined with anti-VEGF drugs in the treatment of diabetic macular edema: a systematic review and meta-analysis. [PDF]

Front Endocrinol (Lausanne)
Chen F, Wang X, Chen M, Xin M, Xian Y.
europepmc   +1 more source

Anti-vascular endothelial growth factor therapies in ophthalmology. [PDF]

Med Hypothesis Discov Innov Ophthalmol
Koksaldi S, Karti O, Saatci AO.
europepmc   +1 more source

Role of intravitreal ranibizumab for rapid recovery of central serous chorioretinopathy

, 2020
Kamran Shahzad, Syed Ahmer Hussain, Muhammad Zafarullah, Nausherwan Adil   +3 more
openalex   +2 more sources

A Pilot Study on Structural Changes of Choroidal Vasculature Following Intravitreal Anti-VEGF Injection in Neovascular Age-Related Macular Degeneration: Faricimab vs Ranibizumab. [PDF]

J Clin Med
Nishiyama T, Hirai H, Miyata K, Nishi T, Ueda T, Kase S.   +5 more
europepmc   +1 more source

Novel Needle for Intravitreal Injections Does Not Affect Biological Activity of Anti-VEGF Drugs. [PDF]

Clin Ophthalmol
Lytvynchuk L, Nolte KL, Fuezy I, Zhou W, Deissler H, Deissler HL.   +5 more
europepmc   +1 more source

Efficacy and Safety of Switching from Ranibizumab to Brolucizumab in Age-Related Macular Degeneration: Multicenter Real-World Outcomes. [PDF]

Clin Ophthalmol
Hejsek L, Hrevuš M, Burova M, Beran D, Cyžová Z, Penčák M, Pařilová T, Liláková D, Veith M.   +8 more
europepmc   +1 more source

Results of treatment of post vitrectomy vitreous hemorrhage in patients with proliferative diabetic retinopathy with the use of ranibizumab

, 2015
O.O. Putienko, A. Abounaceur J. Ait Elhaj, D. Pogorelyi   +2 more
openalex   +1 more source